TCM
AGN

Tuttle Capital Management’s Allergan plc AGN Stock Holding History

Tuttle Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,146
Closed -$1.56M – 132
2019
Q4 		$1.56M Buy
8,146
+2,332
+40% +$421K 0.59% 41
2019
Q3 		$929K Buy
+5,814
New +$947K 0.25% 112
2018
Q4 		– Sell
-10,300
Closed -$1.96M – 164
2018
Q3 		$1.96M Buy
+10,300
New +$1.89M 0.37% 71
2017
Q4 		– Sell
-7,712
Closed -$1.58M – 87
2017
Q3 		$1.58M Buy
7,712
+4,547
+144% +$1.06M 1.56% 18
2017
Q2 		$769K Buy
+3,165
New +$744K 0.6% 34

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tuttle Capital Management's AGN Position: Q1 2020 in Review

Tuttle Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 8,146 shares — an estimated $1.56M sold.

Tuttle Capital Management first reported a position in AGN in Q2 2017 and held it in 5 quarters. The position peaked at $1.96M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Tuttle Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Tuttle Capital Management sold 8,146 Allergan plc shares in Q1 2020, an estimated $1.56M.
  • Tuttle Capital Management first reported a position in Allergan plc in Q2 2017 and held it in 5 quarters.
  • Tuttle Capital Management's Allergan plc position peaked at $1.96M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Tuttle Capital Management's 13F filing for Q1 2020, filed 9 Apr 2020.